[Federal Register Volume 63, Number 230 (Tuesday, December 1, 1998)]
[Notices]
[Page 66199]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-31969]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to section 1301.33(a) of title 21 of the Code of Federal
Regulations (CFR), this is notice that on August 27, 1998, Celgene
Corporation, 7 Powder Horn Drive, Warren, New Jersey 07059, made
application by renewal to the Drug Enforcement Administration (DEA) for
registration as a bulk manufacturer of the basic classes of controlled
substances listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
2, 5-Dimethoxyamphetamine (7396)........... I
4-Methoxyamphetamine (7411)................ I
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
------------------------------------------------------------------------
The firms plans to manufacture amphetamine for distribution of the
bulk active substances to its customers, 4-methoxyamphetamine as an
intermediate in the manufacturer of a non-controlled substance,
methylphenidate for product research and development and 2,5-
dimethoxyamphetamine to develop, manufacture and sell compounds to
pharmaceutical and agrochemical industries.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate,
to the Deputy Assistant Adminstrator, Office of Diversion Control, Drug
Assistant Administrator, Office of Diversion Control, Drug Enforcement
Administration, United States Department of Justice, Washington, DC
20537, Attention: DEA Federal Register Representative (CCR), and must
be filed no later than February 1, 1999.
Dated: November 18, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 98-31969 Filed 11-30-98; 8:45 am]
BILLING CODE 4410-09-M
